Search research articles
Contact Us
Filters
Showing results (351-360 of 433) with videos related to
Page
of 44
Sort By:
Musculoskeletal Science & Practice
|
April 26, 2024
Implementing good life with osteoArthritis from Denmark (GLA:D®) in australian public hospitals. Part 1: Feasibility
Natalie J Collins, Michelle D Smith, Shaun P O'Leary, et al.
The Journal of Biological Chemistry
|
August 27, 2011
Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region
Thomas L Kukar, Thomas B Ladd, Paul Robertson, et al.
Gene Therapy
|
April 10, 2026
Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoids
Mary Tenuta, Morgan Bravo, Alex Olson, et al.
Preventing Chronic Disease
|
February 18, 2010
Perceptions of cardiovascular health in underserved communities
Lucinda L Bryant, Nancy P Chin, Lesley A Cottrell, et al.
Journal of Virology
|
April 7, 2017
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes
Rajesh P Ringe, Gabriel Ozorowski, Anila Yasmeen, et al.
NPJ Vaccines
|
March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers
Iván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2021
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
Hannah L Turner, Raiees Andrabi, Christopher A Cottrell, et al.
Trials
|
October 16, 2015
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
Claire M Rice, David I Marks, Yoav Ben-Shlomo, et al.
Plos Pathogens
|
February 8, 2021
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
Tysheena P Charles, Samantha L Burton, Prabhu S Arunachalam, et al.
Science Advances
|
June 18, 2020
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
Bartek Nogal, Laura E McCoy, Marit J van Gils, et al.
Page
of 44
Search research articles
Search
Showing results (351-360 of 433) with videos related to
Sort By:
Page
of 44
Musculoskeletal Science & Practice
|
April 26, 2024
Implementing good life with osteoArthritis from Denmark (GLA:D®) in australian public hospitals. Part 1: Feasibility
Natalie J Collins, Michelle D Smith, Shaun P O'Leary, et al.
The Journal of Biological Chemistry
|
August 27, 2011
Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region
Thomas L Kukar, Thomas B Ladd, Paul Robertson, et al.
Gene Therapy
|
April 10, 2026
Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoids
Mary Tenuta, Morgan Bravo, Alex Olson, et al.
Preventing Chronic Disease
|
February 18, 2010
Perceptions of cardiovascular health in underserved communities
Lucinda L Bryant, Nancy P Chin, Lesley A Cottrell, et al.
Journal of Virology
|
April 7, 2017
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes
Rajesh P Ringe, Gabriel Ozorowski, Anila Yasmeen, et al.
NPJ Vaccines
|
March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers
Iván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2021
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
Hannah L Turner, Raiees Andrabi, Christopher A Cottrell, et al.
Trials
|
October 16, 2015
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
Claire M Rice, David I Marks, Yoav Ben-Shlomo, et al.
Plos Pathogens
|
February 8, 2021
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
Tysheena P Charles, Samantha L Burton, Prabhu S Arunachalam, et al.
Science Advances
|
June 18, 2020
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
Bartek Nogal, Laura E McCoy, Marit J van Gils, et al.
Page
of 44